Treatment challenges in methicillin resistant Staphylococcus aureus infections Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen? Year: 2006
Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infections Source: Eur Respir J 2002; 20: 3S-8S Year: 2002
Staphlococcus aureus : susceptibility to antibacterial drugs and rate of MRSASource: Eur Respir J 2006; 28: Suppl. 50, 788s Year: 2006
Mechanisms of acquisition of resistance in Staphylococcus aureus Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen? Year: 2006
Increasing global resistance to penicillin, macrolides and other antimicrobials among isolates of Streptococcus pneumoniae : susceptibility data from three years of the PROTEKT surveillance study Source: Eur Respir J 2003; 22: Suppl. 45, 486s Year: 2003
Resistance of Streptococcus pneumoniae to penicillin, azitromycin, ciprofloxacyn and ceftriaxon Source: Eur Respir J 2001; 18: Suppl. 33, 140s Year: 2001
Therapeutic efficacy of macrolides, minocycline and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012
Quinolones consume and streptococcus pneumoniae antibiotic resistance Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007
MRSA specific scores promote overuse of anti-MRSA antibiotics Source: International Congress 2019 – Pneumonia in 2019: antimicrobial resistance, cardiovascular complications and diagnosis Year: 2019
Long-term, low-dose azithromycin treatment reduces the prevalence of staphylococcus aureus , but selects for macrolide resistance in Danish CF-patients Source: Annual Congress 2007 - Cystic fibrosis: the balance between treatment and side-effects Year: 2007
Chronic use of azithromycin in CF is associated with a substantial increase in macrolide resistance of S. aureus and haemophilus Source: Annual Congress 2006 - Cystic fibrosis lung disease: molecules images and drugs Year: 2006
Prevention of MRSA pneumonia by oral vancomycin decontamination: a randomised trial Source: Eur Respir J 2004; 23: 921-926 Year: 2004
Survival benefit of beta-lactam plus macrolide combined therapy versus beta-lactam plus quinolones in hospitalized community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies Year: 2016
Safety and efficacy of linezolid, clarithromycin and capreomycin in the treatment of multi-drug resistant pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 587s Year: 2006
Antimicrobial susceptibility of atypical pathogens Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007
Activity of N-acetylcysteine in combination with colistin against a collection of colistin resistant Acinetobacter baumannii clinical isolates Source: International Congress 2017 – How can microbiology and translational research help physicians? Year: 2017
Effects of macrolides on pneumolysin of macrolide-resistant Streptococcus pneumoniae Source: Eur Respir J 2006; 27: 1020-1025 Year: 2006
Is bedaquiline as effective as fluoroquinolones in the treatment of multidrug-resistant tuberculosis? Source: Eur Respir J 2016; 48: 582-585 Year: 2016
Biological resistance to beta-lactamic antibiotics in patients with respiratory infection in the prediction of efficiency of antibacterial therapy Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020